Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04659603
Title Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors (CARMEN-BT01)
Acronym CARMEN-BT01
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | NLD | HUN | ESP | ARG

Facility Status City State Zip Country Details
AdventHealth Orlando Site Number : 8400001 Orlando Florida 32804 United States Details
Massachusetts General Hospital Site Number : 8400002 Boston Massachusetts 02114 United States Details
University of Wisconsin Site Number : 8400004 Madison Wisconsin 53792 United States Details
Investigational Site Number : 0320003 Capital Federal Buenos Aires 1012 Argentina Details
Investigational Site Number : 0320001 Pergamino Buenos Aires B2700CPM Argentina Details
Investigational Site Number : 0320002 Rosario Santa Fe 2000 Argentina Details
Investigational Site Number : 1520002 Temuco La Araucanía 4800827 Chile Details
Investigational Site Number : 1520003 Santiago Reg Metropolitana De Santiago 7500921 Chile Details
Investigational Site Number : 1520001 Santiago Reg Metropolitana De Santiago 8420383 Chile Details
Investigational Site Number : 3480003 Budapest 1122 Hungary Details
Investigational Site Number : 4100003 Goyang-si Gyeonggi-do 10408 Korea, Republic of Details
Investigational Site Number : 4100001 Seoul Seoul-teukbyeolsi 03080 Korea, Republic of Details
Investigational Site Number : 4100002 Seoul Seoul-teukbyeolsi 06351 Korea, Republic of Details
Investigational Site Number : 5280002 Amsterdam 1066 CX Netherlands Details
Investigational Site Number : 5280001 Rotterdam 3015 GD Netherlands Details
Investigational Site Number : 5280003 Utrecht 3584 CX Netherlands Details
Investigational Site Number : 6430001 Moscow 115478 Russian Federation Details
Investigational Site Number : 6430004 Pushkin, Saint- Petersburg 196603 Russian Federation Details
Investigational Site Number : 6430002 Saint -Petersburg 197758 Russian Federation Details
Investigational Site Number : 7240001 Barcelona Barcelona [Barcelona] 08035 Spain Details
Investigational Site Number : 7240003 Madrid Madrid, Comunidad De 28046 Spain Details
Investigational Site Number : 7240002 Majadahonda Madrid 28222 Spain Details
Investigational Site Number : 1580001 Taichung 40447 Taiwan Details
Investigational Site Number : 1580002 Tainan 704 Taiwan Details
Investigational Site Number : 1580003 Taipei 11217 Taiwan Details
Investigational Site Number : 7920003 Adana 01250 Turkey Details
Investigational Site Number : 7920004 Ankara 06100 Turkey Details
Investigational Site Number : 7920001 Istanbul 34722 Turkey Details
Investigational Site Number : 7920002 Izmir Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field